Ruel M A, Rubens F D
Division of Cardiac Surgery, University of Ottawa Heart Institute, Ontario, Canada.
Can J Anaesth. 2001 Apr;48(4 Suppl):S13-23.
Of all surgical specialties, cardiac operations are most often associated with coagulopathy, blood loss, and the need for transfusions. This not only represents a major burden on blood procurement and banking organizations at all levels, but also constitutes a risk for each patient receiving allogeneic blood products. This paper reviews current non-pharmacological strategies aimed at decreasing blood use in patients undergoing cardiac surgery.
The literature pertaining to each blood conservation strategy was searched, reviewed, and appraised. Meta- analyses were also consulted and their results complemented with subsequent reports when available.
Preoperative autologous donation programs are effective in decreasing allogeneic transfusions, but are costly and applicable to elective patients only. Off-pump revascularization strategies also appear to decrease transfusion requirements in suitable patients. The effectiveness of acute normovolemic hemodilution, retrograde autologous priming, small volume cardiopulmonary bypass circuits, platelet-rich plasmapheresis, alternative heparin strategies, and postoperative cell salvage are more difficult to appraise as a high proportion of available studies suffer from lack of transfusion guidelines or the absence of blinding. Biological glues, surgical adhesives, and postoperative increases in positive end-expiratory pressure (PEEP) have no demonstrated efficacy.
The applicability or effectiveness of many of these modalities remains controversial and more studies are needed before they may be employed routinely in cardiac surgical patients. The judicious use of rational transfusion guidelines may still be the simplest and most cost-effective means of blood conservation today.
在所有外科专业中,心脏手术最常与凝血病、失血及输血需求相关。这不仅给各级血液采集和储存机构带来重大负担,也给每一位接受异体血制品的患者构成风险。本文综述了旨在减少心脏手术患者用血的当前非药物策略。
检索、回顾并评估了与每种血液保护策略相关的文献。还查阅了荟萃分析,并在有后续报告时对其结果进行补充。
术前自体献血计划在减少异体输血方面有效,但成本高昂且仅适用于择期手术患者。非体外循环血管重建策略似乎也能减少合适患者的输血需求。急性等容性血液稀释、逆行自体预充、小容量体外循环回路、富含血小板血浆置换、替代肝素策略及术后细胞回收的有效性更难评估,因为现有研究中有很大比例缺乏输血指南或未采用盲法。生物胶、手术粘合剂及术后呼气末正压(PEEP)增加未显示出疗效。
这些方法中的许多方法的适用性或有效性仍存在争议,在可常规应用于心脏手术患者之前还需要更多研究。明智地使用合理的输血指南可能仍是当今最简单且最具成本效益的血液保护手段。